lifenutrition.center Skip to main content

20: This stores shipping department will be closed from Oct 18th until October 22nd. You can still place your orders and we will resume shipping on Oct 25th.

 

NeuroScience TravaGen 120 Capsules

NeuroScience

$64.00
(No reviews yet) Write a Review
SKU:
NS0018
UPC:
659468101134
Condition:
New
Availability:
In Stock
Disclaimer:
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Adding to cart… The item has been added

Contains a blend of ingredients important for mood and reducing stress*
Utilizes L-tryptophan to provide gentler conversion to serotonin compared to 5-HTP*

Key ingredients
L-tryptophan: An essential amino acid and precursor to serotonin and melatonin. L-tryptophan provides gentler conversion to serotonin compared to 5-hydroxytryptophan (5-HTP) as the rate-limiting step in the synthesis of serotonin is the conversion of L-tryptophan to 5-HTP (1). Serotonin is important for regulating mood and sleep-wake function (2).

Taurine: Neuroprotective amino acid that provides antioxidant protection and demonstrates GABA-A agonist activity (3-5).* GABA is the primary inhibitory neurotransmitter in the brain important for calm and sleep (6-8).

L-theanine: Amino acid that acts as a glutamate receptor antagonist (9).* Glutamatergic signaling plays a role in underlying mechanisms related to anxiousness and stress (10). In a randomized, double-blind, placebo-controlled study, L-theanine was shown to significantly reduce stress (11).*

Vitamins B and C: Active forms of vitamin B6, folate, B12, and C are important for serotonin synthesis (12-16).*

References

  1. Birdsall T. Altern Med Rev. 1988;3(4):271-80.
  2. Monti J. Sleep Med Rev. 2011;15(4):269-81.
  3. Kumari N, et al. Adv Exp Med Biol. 2013;775:19-27.
  4. Shimada K, et al. Adv Exp Med Biol. 2015;803:581-96.
  5. Kletke O, et al. PLoS One. 2013;8(4):e61733.
  6. Gou Z, et al. Dongwuxue Yanjiu. 2012;33(E5-6):E75-81.
  7. Mohler H. Neuropharmacology. 2012;62(1):42-53.
  8. Saper C, et al. Nature. 2005;437(7063):1257-63.
  9. Kakuda T, et al. Biosci Biotechnol Biochem. 2002;66(12):2683-2686.
  10. Bermudo-Soriano C, et al. Pharmacol Biochem Behav. 2012;100(4):752-74.
  11. Kimura K, et al. Biol Psychol. 2007; 74(1):39-45.
  12. Dakshinamurti K, et al. Ann N Y Acad Sci. 1990;585:128-44.
  13. Bottiglieri T. Psychiatr Clin North Am. 2013;36(1):1-13.
  14. Stahl S. J Clin Psychiatry. 2008;69(9):1352-3.
  15. Antoniades C, et al. Circulation. 2006;114(11):1193-201.
  16. May J, et al. Brain Res Bull. 2013;90:35-42.